Evidence map›Paper›PMID 30815387›Full record

ArticleJournal of advanced pharmaceutical technology & research

Assessment of the fitness of Cox and parametric regression models of survival distribution for Iranian breast cancer patients' data.

Maryam Mohseny, Reza Shekarriz-Foumani, Parastoo Amiri, Marjan Vejdani, Pezhman Farshidmehr, Hossein Zabihi Mahmoudabadi, Farzaneh Amanpour, Pegah Mohaghegh, Farzad Tajdini, Azadeh Sayarifard and 1 more

Abstract read
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maryam MohsenyDepartments of Health and Community Medicine, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza Shekarriz-FoumaniDepartment of Community Medicine, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Parastoo AmiriIranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Marjan VejdaniIranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Pezhman FarshidmehrDepartment of Vascular Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hossein Zabihi MahmoudabadiDepartment of Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farzaneh AmanpourDepartment of Epidemiology and Biostatistics, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
Pegah MohagheghDepartment of Community Medicine, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Farzad TajdiniDepartments of Health and Community Medicine, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azadeh SayarifardCommunity Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Esmat Davoudi-MonfaredHealth Management Research Center & Department of Community Medicine, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Factors affecting the time of survival after breast cancer (BC) diagnosis remain unknown. However, some of the prognostic factors have been identified. The aim of this study was to investigate the effects of biologic and socioeconomic factors on long-term survival of BC patients. This was a descriptive chart review and survey of all women with a confirmed diagnosis of BC registered in Shohada-e-Tajrish Cancer Research Center database from March 2004 to March 2015. The checklist of study consisted of biologic, demographic, reproductive, genetic, medical, and therapeutic information of patients. The minimum time of follow-up was 3 years and the maximum was 10 years. We then evaluated possible associations of these variables with BC survival using Cox and parametric regression models of survival analysis. The study population was 1276 BC patients. Their mean survival was 23 (range 1-120) months. Between the parametric models, Weibull regression model demonstrated the lowest Akaike information criterion and thus the best fit, and tumor size, number of lymph nodes, BC stage, educational level, and high-fat diet were significant in this model. Based on our findings, educational level, consumption of fat, and characteristics of tumor at the time of diagnosis (disease stage, tumor size, number of involved lymph nodes) are the most important prognostic factors affecting long-term survival of BC patients. We suggest that future studies assess the efficacy of possible interventions for these factors.

Indexed as

Breast cancerhazard modelsIransurvival

Identifiers

PMID30815387
PMCPMC6383351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.